2/29
10:32 am
bmrn
Rating for BMRN
Low
Report
Rating for BMRN
2/23
01:09 pm
bmrn
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $100.00 price target on the stock.
Low
Report
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $100.00 price target on the stock.
2/23
12:16 pm
bmrn
Rating for BMRN
Low
Report
Rating for BMRN
2/23
10:56 am
bmrn
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $100.00 price target on the stock.
Low
Report
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $100.00 price target on the stock.
2/23
10:56 am
bmrn
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $100.00 price target on the stock.
Low
Report
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $100.00 price target on the stock.
2/23
10:45 am
bmrn
Rating for BMRN
Low
Report
Rating for BMRN
2/23
10:45 am
bmrn
Rating for BMRN
Low
Report
Rating for BMRN
1/30
01:36 pm
bmrn
Rating for BMRN
Low
Report
Rating for BMRN
1/30
01:36 pm
bmrn
Rating for BMRN
Low
Report
Rating for BMRN